Synthesis of Therapeutic Agents The promoter used for cloning HBV surface antigen is polyhedrin alcohol dehydrogenase 1 β-galactosidase galactokinase polyhedrin alcohol dehydrogenase 1 β-galactosidase galactokinase ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The recombinant hGH lacks terminal arginine terminal methionine terminal lysine terminal glutamine terminal arginine terminal methionine terminal lysine terminal glutamine ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents How is human insulin synthesized using recombinant DNA technology? By using chemically synthesized DNA sequences for the two chains separately By using chemically synthesized DNA sequences for the complete insulin protein By using cDNA for insulin By isolating DNA from the islets of Langerhans of pancreas By using chemically synthesized DNA sequences for the two chains separately By using chemically synthesized DNA sequences for the complete insulin protein By using cDNA for insulin By isolating DNA from the islets of Langerhans of pancreas ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents In India first genetically engineered vaccine against HBV was developed by Ranbaxy Pvt Ltd Glaxo Pvt Ltd Shantha Biotechnics Pvt Ltd Dabur Pvt Ltd Ranbaxy Pvt Ltd Glaxo Pvt Ltd Shantha Biotechnics Pvt Ltd Dabur Pvt Ltd ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The gene coding for VP1 is cloned in pUC 18 pMB 9 pBR 322 pUC 19 pUC 18 pMB 9 pBR 322 pUC 19 ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Human insulin formed by recombinant DNA technology is known as humulin R insulin huinsulin H insulin humulin R insulin huinsulin H insulin ANSWER DOWNLOAD EXAMIANS APP
EXAMIANS